… review summarises currently registered large clinical trials of therapeutic agents for COVID-19.
… Prophylaxis trials We found 12 trials assessing prophylactic agents for COVID-19 (Box 2). …

… Under Research Exclusion (SECURE-IBD) helped to identify the ineffectiveness of
hydroxychloroquine as a prophylactic therapy for infection with SARS-CoV2 (110) and the potential …

… or chloroquine for prophylaxis against COVID-19. In RCTs and … with hydroxychloroquine to
treat COVID-19 were often conflicting… therapy for the treatment of coronavirus disease 2019 (…

… In designing mAb therapies for prophylaxis, a major goal is … a mAb used for the prophylaxis
of respiratory syncytial virus which … Prophylactic administration of the Evusheld™ cocktail was …

… anticoagulation (first hypothesis) and statin therapy vs matching placebo (second … COVID-19,
intermediate-dose prophylactic anticoagulation, compared with standard-dose prophylactic …

… with COVID-19 given an anticoagulant as a therapeutic or intermediate dose and those given
a prophylactic … In two previous RCTs [18,19], the incidence of thrombosis in the therapeutic …

… Therefore, additional studies are needed to confirm our findings and assess the impact of
anticoagulation therapy on the long‐term effects of COVID‐19. Several other trials …

… the prophylaxis and treatment of COVID-19-related disease. In a small study on patients
with COVID-19 … [ 7 ] This drug may also have therapeutic potential for use in COVID-19-related …

… Coronavirus-2019 (COVID-19) predisposes patients to … The prevalence of venous
thromboembolism in COVID-19 patients … seems more specific for COVID-19 and is associated with …

… To envisage possible therapeutic/ prophylactic strategies for COVID-19, it is inevitable to
comprehensively understand the background of the diseases process with thorough insight into …